德寶集團控股(08436.HK)前三季度純利升33.27%至3580.5萬港元
格隆匯11月13日丨德寶集團控股(08436.HK)公佈,截至2019年9月30日止9個月,公司實現收益2.33億港元,同比增長13.18%;股東應占盈利3580.5萬港元,同比增長33.27%;基本及攤薄每股盈利8.95港仙,不建議派息。
公告稱,增長的主要受惠於報告期內,接獲較多的銷售訂單影響,而這又由於公司高質量產品受越來越多的客户認同,以及現有客户對整體產品的支持,同時管理層成功運用營銷策略持續物色新客户。
期內,集團的毛利約為8860萬港元,較上年同期增加約42.6%,毛利率升至38.1%,乃主要由於期內,不同的產品組合,以及受惠人民幣兑港幣貶值影響,生產成本相對便宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.